Alexander Nowak
Stock Analyst at Craig-Hallum
(4.39)
# 382
Out of 4,711 analysts
47
Total ratings
54.29%
Success rate
20.15%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Buy | $121 → $157 | $161.88 | -3.01% | 4 | Nov 13, 2024 | |
| CVRX CVRx, Inc. | Maintains: Buy | $15 → $20 | $12.11 | +65.15% | 4 | Nov 4, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $10.67 | +59.33% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $44.84 | +27.12% | 6 | Sep 5, 2024 | |
| CELC Celcuity | Assumes: Buy | $25 → $27 | $12.46 | +116.69% | 2 | May 16, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $20.61 | -27.22% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $6.41 | +24.80% | 4 | Apr 24, 2024 | |
| AXDX Accelerate Diagnostics | Maintains: Hold | $2 → $1 | $1.16 | -13.79% | 3 | Apr 1, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $6.15 | +192.68% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $35.91 | +39.24% | 2 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $0.80 | +900.00% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $59.40 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.76 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.31 | +376.19% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $73.17 | +50.33% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $0.46 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $4.98 | +5,924.10% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $8.31 | +236.94% | 1 | Aug 31, 2020 |
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $161.88
Upside: -3.01%
CVRx, Inc.
Nov 4, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $12.11
Upside: +65.15%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $10.67
Upside: +59.33%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $44.84
Upside: +27.12%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $12.46
Upside: +116.69%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $20.61
Upside: -27.22%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $6.41
Upside: +24.80%
Accelerate Diagnostics
Apr 1, 2024
Maintains: Hold
Price Target: $2 → $1
Current: $1.16
Upside: -13.79%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $6.15
Upside: +192.68%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $35.91
Upside: +39.24%
May 12, 2023
Maintains: Buy
Price Target: $14 → $8
Current: $0.80
Upside: +900.00%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $59.40
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.76
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.31
Upside: +376.19%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $73.17
Upside: +50.33%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.46
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $4.98
Upside: +5,924.10%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $8.31
Upside: +236.94%